Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Major changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.
    Difference
    12%
    Check dated 2025-10-06T05:31:45.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:05:37.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.
    Difference
    0.7%
    Check dated 2025-09-14T19:25:07.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.7%
    Check dated 2025-09-07T16:43:28.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    19%
    Check dated 2025-08-31T12:04:23.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T04:25:12.000Z thumbnail image

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.